These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28400028)

  • 1. Predicting Clinical and Echocardiographic Response After Cardiac Resynchronization Therapy With a Score Combining Clinical, Electrocardiographic, and Echocardiographic Parameters.
    Bernard A; Menet A; Marechaux S; Fournet M; Schnell F; Guyomar Y; Leclercq C; Mabo P; Fauchier L; Donal E
    Am J Cardiol; 2017 Jun; 119(11):1797-1802. PubMed ID: 28400028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined score using clinical, electrocardiographic, and echocardiographic parameters to predict left ventricular remodeling in patients having had cardiac resynchronization therapy six months earlier.
    Brunet-Bernard A; Maréchaux S; Fauchier L; Guiot A; Fournet M; Reynaud A; Schnell F; Leclercq C; Mabo P; Donal E
    Am J Cardiol; 2014 Jun; 113(12):2045-51. PubMed ID: 24793667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events.
    Park JH; Negishi K; Grimm RA; Popovic Z; Stanton T; Wilkoff BL; Marwick TH
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):864-72. PubMed ID: 24084489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
    Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
    Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
    Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy.
    van der Bijl P; Khidir M; Leung M; Mertens B; Ajmone Marsan N; Delgado V; Bax JJ
    Eur J Heart Fail; 2017 Sep; 19(9):1145-1151. PubMed ID: 28176418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular regional remodeling and lead position during cardiac resynchronization therapy.
    Kronborg MB; Sommer A; Fyenbo DB; Norgaard BL; Gerdes C; Jensen JM; Jensen HK; Kristensen J; Nielsen JC
    Heart Rhythm; 2018 Oct; 15(10):1542-1549. PubMed ID: 29678780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of long-term mortality with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block.
    Biton Y; Costa J; Zareba W; Baman JR; Goldenberg I; McNitt S; Solomon SD; Polonsky B; Kutyifa V
    Clin Cardiol; 2018 Oct; 41(10):1358-1366. PubMed ID: 30141210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating Electromechanical From Non-Electrical Substrates of Mechanical Discoordination to Identify Responders to Cardiac Resynchronization Therapy.
    Lumens J; Tayal B; Walmsley J; Delgado-Montero A; Huntjens PR; Schwartzman D; Althouse AD; Delhaas T; Prinzen FW; Gorcsan J
    Circ Cardiovasc Imaging; 2015 Sep; 8(9):e003744. PubMed ID: 26338877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QRS fusion complex analysis using wave interference to predict reverse remodeling during cardiac resynchronization therapy.
    Sweeney MO; Hellkamp AS; van Bommel RJ; Schalij MJ; Borleffs CJ; Bax JJ
    Heart Rhythm; 2014 May; 11(5):806-13. PubMed ID: 24462523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Degree of Left Ventricular Remodeling on Clinical Outcomes From Cardiac Resynchronization Therapy.
    Shamoun F; De Marco T; DeMets D; Mei C; Lindenfeld J; Saxon LA; Boehmer JP; Leigh J; Yong P; Feldman AM; Bristow MR
    JACC Heart Fail; 2019 Apr; 7(4):281-290. PubMed ID: 30738980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of global longitudinal strain in heart failure patients treated with cardiac resynchronization therapy.
    Khidir MJH; Abou R; Yilmaz D; Ajmone Marsan N; Delgado V; Bax JJ
    Heart Rhythm; 2018 Oct; 15(10):1533-1539. PubMed ID: 29604420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of left ventricular pacing site plus multipoint pacing improves remodeling and clinical response to cardiac resynchronization therapy at 1 year.
    Zanon F; Marcantoni L; Baracca E; Pastore G; Lanza D; Fraccaro C; Picariello C; Conte L; Aggio S; Roncon L; Pacetta D; Badie N; Noventa F; Prinzen FW
    Heart Rhythm; 2016 Aug; 13(8):1644-51. PubMed ID: 27450156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial function, a new predictor of response to cardiac resynchronization therapy?
    Feneon D; Behaghel A; Bernard A; Fournet M; Mabo P; Daubert JC; Leclercq C; Donal E
    Heart Rhythm; 2015 Aug; 12(8):1800-6. PubMed ID: 25896013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronization therapy restored ventricular septal myocardial perfusion and enhanced ventricular remodeling in patients with nonischemic cardiomyopathy presenting with left bundle branch block.
    Ogano M; Iwasaki YK; Tanabe J; Takagi H; Umemoto T; Hayashi M; Miyauchi Y; Shimizu W
    Heart Rhythm; 2014 May; 11(5):836-41. PubMed ID: 24561161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Piccolo R; Galasso G; Reiter RJ
    Int J Cardiol; 2016 Oct; 221():359-63. PubMed ID: 27404706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2D/3D Echocardiographic features of patients with reverse remodeling after cardiac resynchronization therapy.
    Cimino S; Maestrini V; Cantisani D; Petronilli V; Filomena D; Gatto MC; Birtolo LI; Piro A; Lavalle C; Agati L
    Echocardiography; 2019 Aug; 36(8):1475-1481. PubMed ID: 31260156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.
    Sebag FA; Martins RP; Defaye P; Hidden-Lucet F; Mabo P; Daubert JC; Leclercq C
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1219-27. PubMed ID: 22697464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular scar impact on left ventricular synchronization parameters and outcomes of cardiac resynchronization therapy.
    Ahmed W; Samy W; Tayeh O; Behairy N; Abd El Fattah A
    Int J Cardiol; 2016 Nov; 222():665-670. PubMed ID: 27517660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.